REPORT ID 6508

United States Tissue Diagnostics Instrument Market Report 2017

Publish Date
26-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Tissue Diagnostics Instrument market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Tissue Diagnostics Instrument in these regions, from 2012 to 2022 (forecast).

United States Tissue Diagnostics Instrument market competition by top manufacturers/players, with Tissue Diagnostics Instrument sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche (Switzerland)
    Danaher (US)
    Thermo Fisher Scientific (US)
    Abbott (US)
    Agilent Technologies (US)
    Merck (Germany)
    Sakura Finetek Japan (Japan)
    Abcam (UK)
    BD (US)
    QIAGEN (Netherlands)
    Sienna Cancer Diagnostics (Australia)
    Royal Philips (Netherlands)
    A. Menarini Diagnostics (Italy)
    Cell Signaling Technology (US)
    Enzo Life Sciences (US)
    Master Diagn?stica (Spain)
    TissueGnostics (Austria)
    Bio SB (US)
    MedImmune (US)
    Cernostics (US)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Slide-staining Systems
    Scanners
    Tissue-processing Systems
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Breast cancer
    Gastric cancer
    Lymphoma
    Prostate cancer
    Non-small cell lung cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Tissue Diagnostics Instrument Market Report 2017
1 Tissue Diagnostics Instrument Overview
    1.1 Product Overview and Scope of Tissue Diagnostics Instrument
    1.2 Classification of Tissue Diagnostics Instrument by Product Category
        1.2.1 United States Tissue Diagnostics Instrument Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Tissue Diagnostics Instrument Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Slide-staining Systems
        1.2.4 Scanners
        1.2.5 Tissue-processing Systems
        1.2.6 Others
    1.3 United States Tissue Diagnostics Instrument Market by Application/End Users
        1.3.1 United States Tissue Diagnostics Instrument Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Breast cancer
        1.3.3 Gastric cancer
        1.3.4 Lymphoma
        1.3.5 Prostate cancer
        1.3.6 Non-small cell lung cancer
        1.3.7 Others
    1.4 United States Tissue Diagnostics Instrument Market by Region
        1.4.1 United States Tissue Diagnostics Instrument Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Tissue Diagnostics Instrument Status and Prospect (2012-2022)
        1.4.3 Southwest Tissue Diagnostics Instrument Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Tissue Diagnostics Instrument Status and Prospect (2012-2022)
        1.4.5 New England Tissue Diagnostics Instrument Status and Prospect (2012-2022)
        1.4.6 The South Tissue Diagnostics Instrument Status and Prospect (2012-2022)
        1.4.7 The Midwest Tissue Diagnostics Instrument Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Tissue Diagnostics Instrument (2012-2022)
        1.5.1 United States Tissue Diagnostics Instrument Sales and Growth Rate (2012-2022)
        1.5.2 United States Tissue Diagnostics Instrument Revenue and Growth Rate (2012-2022)

2 United States Tissue Diagnostics Instrument Market Competition by Players/Suppliers
    2.1 United States Tissue Diagnostics Instrument Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Tissue Diagnostics Instrument Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Tissue Diagnostics Instrument Average Price by Players/Suppliers (2012-2017)
    2.4 United States Tissue Diagnostics Instrument Market Competitive Situation and Trends
        2.4.1 United States Tissue Diagnostics Instrument Market Concentration Rate
        2.4.2 United States Tissue Diagnostics Instrument Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Tissue Diagnostics Instrument Manufacturing Base Distribution, Sales Area, Product Type

3 United States Tissue Diagnostics Instrument Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Tissue Diagnostics Instrument Sales and Market Share by Region (2012-2017)
    3.2 United States Tissue Diagnostics Instrument Revenue and Market Share by Region (2012-2017)
    3.3 United States Tissue Diagnostics Instrument Price by Region (2012-2017)

4 United States Tissue Diagnostics Instrument Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Tissue Diagnostics Instrument Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Tissue Diagnostics Instrument Revenue and Market Share by Type (2012-2017)
    4.3 United States Tissue Diagnostics Instrument Price by Type (2012-2017)
    4.4 United States Tissue Diagnostics Instrument Sales Growth Rate by Type (2012-2017)

5 United States Tissue Diagnostics Instrument Sales (Volume) by Application (2012-2017)
    5.1 United States Tissue Diagnostics Instrument Sales and Market Share by Application (2012-2017)
    5.2 United States Tissue Diagnostics Instrument Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Tissue Diagnostics Instrument Players/Suppliers Profiles and Sales Data
    6.1 Roche (Switzerland)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roche (Switzerland) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Danaher (US)
        6.2.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Danaher (US) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Thermo Fisher Scientific (US)
        6.3.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Thermo Fisher Scientific (US) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abbott (US)
        6.4.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abbott (US) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Agilent Technologies (US)
        6.5.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Agilent Technologies (US) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck (Germany)
        6.6.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck (Germany) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sakura Finetek Japan (Japan)
        6.7.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sakura Finetek Japan (Japan) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Abcam (UK)
        6.8.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Abcam (UK) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 BD (US)
        6.9.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 BD (US) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 QIAGEN (Netherlands)
        6.10.2 Tissue Diagnostics Instrument Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 QIAGEN (Netherlands) Tissue Diagnostics Instrument Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Sienna Cancer Diagnostics (Australia)
    6.12 Royal Philips (Netherlands)
    6.13 A. Menarini Diagnostics (Italy)
    6.14 Cell Signaling Technology (US)
    6.15 Enzo Life Sciences (US)
    6.16 Master Diagn?stica (Spain)
    6.17 TissueGnostics (Austria)
    6.18 Bio SB (US)
    6.19 MedImmune (US)
    6.20 Cernostics (US)

7 Tissue Diagnostics Instrument Manufacturing Cost Analysis
    7.1 Tissue Diagnostics Instrument Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Tissue Diagnostics Instrument

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Tissue Diagnostics Instrument Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Tissue Diagnostics Instrument Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Tissue Diagnostics Instrument Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Tissue Diagnostics Instrument Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Tissue Diagnostics Instrument Sales Volume Forecast by Type (2017-2022)
    11.3 United States Tissue Diagnostics Instrument Sales Volume Forecast by Application (2017-2022)
    11.4 United States Tissue Diagnostics Instrument Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer